UNSPSC 51322602: Pantethine

This classification denotes a nutritional supplement, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7K81IL792L. European Medicines Agency schedules Pantethine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14755MIG. Pantethine generally arises in the molecular formula C22H42N4O8S2. The term 'pantethine' is an International Nomenclature of Cosmetic Ingredients designation. As of Q4 2014, PANTETHINE remains the US FDA Preferred Term for this commodity.

Pantethine bears US NLM identifiers UMLS ID C0070034 and NCI Concept Code C87342. SMILES: S(SCCNC(=O)CCNC(=O)C(O)C(CO)(C)C)CCNC(=O)CCNC(=O)C(O)C(CO)(C)C.

UNSPSC 51322602 Pantethine is a Commodity code that captures pharmaceutical and over-the-counter product procurement by state and local healthcare, fire, and human services agencies. State and local governments buy pharmaceuticals under this code through three primary channels: direct procurement of emergency medical supplies for fire and rescue services, cooperative purchasing agreements for multi-state distribution of generic medications, and information-gathering initiatives around direct-to-manufacturer pharmacy programs. Recent solicitations show city fire departments, state health and human services commissions, and multi-state purchasing cooperatives soliciting advanced life support medications, generic multi-source pharmaceuticals, over-the-counter products, and prescription fulfillment capacity. Issuing bodies span municipal fire rescue services (such as Tampa Fire Rescue), state health and human services agencies (such as Texas HHS), and regional cooperative purchasing vehicles (such as the Minnesota Multistate Cooperative Purchasing Alliance serving multiple states).

Activity concentrates in Florida, Texas, and the Upper Midwest. The City of Tampa's Purchasing Department issued an Invitation for Bids (IFB) in April 2026 seeking Advanced Life Support Medications — 370 units of Labetalol, 1,810 units of Epinephrine, 330 units of Adenosine, and 1,020 units of Diltiazem — with a bid due date of April 8, 2026 and an estimated contract value of $40,000; the award carries a one-year term with options to renew for two additional years and includes a 5 percent bid discount for Small Local Business Enterprise participation not to exceed $10,000. The Minnesota Department of Administration's Office of State Procurement administered a Request for Proposal through MMCAP closing March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, with products required to be available by May 15, 2026 and awards effective July 1, 2026; evaluation weighted price competitiveness at 75 percent and required vendors to maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson). The Texas Health and Human Services Commission issued a Request for Information in April 2026 exploring direct-to-manufacturer prescription programs to inform future formal procurement.